Live Webinar on Breast Cancer in Two Weeks!

開課日期：2024.10.29
上課時間：
課程價格：NT. 0
加入購物車
立即結帳

課程介紹

PharmacyUpdates2024-600x159
 

Novel Therapies for Treating ESR1 and RET-Fusion Mutations in Breast Cancer
 
Join us for this live webinar in an ongoing educational series designed for pharmacists, physicians, nurses, advanced practice providers, and other members of the interprofessional oncology care team!
Register today to learn from expert pharmacy specialists about clinical considerations and management strategies for patients with cancer.
In Two Weeks! Tuesday, October 29, 2024
1:00 – 2:00 PM EDT (UTC -4)
 

Presented By:

IndorfA_300x300 Amy Ly Indorf, PharmD, BCOP
Fred Hutchinson Cancer Center
   

Learning Objectives:

Following this activity, participants should be able to:

  • Describe the prevalence of ESR1 and RET-fusion mutations in locally advanced and metastatic breast cancer.
  • Illustrate the role of targeted agents for ESR1 and RET-fusion mutations in the setting of locally advanced or metastatic breast cancer.
  • Discuss key patient counseling and monitoring considerations for the use of elacestrant and selpercatinib in locally advanced or metastatic breast cancer.
     

CTA-RegisterNow-200x50

 

Fees:
There is no fee to attend this webinar.

Accreditation:
This educational program is approved for continuing education credit for pharmacists, physicians, nurses, PAs, and other oncology professionals.
View full accreditation information here.

Upcoming Pharmacy Updates Webinars:

Recorded Presentations:
Access recorded presentations from this series here.

Supporters:
This activity is supported by educational grants from GSK and Menarini-Stemline. This educational activity is supported by a medical education grant from Exelixis, Inc. This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
購物車 會員登入